Logo

American Heart Association

  2
  0


Final ID: Sa1073

Association between Clinical Characteristics and Telomere Length - Factor Analysis of Mixed Data (FAMD)-based Cluster Analysis

Abstract Body (Do not enter title and authors here): Introduction: Telomere length is a marker of cellular aging and is correlated with various cardiovascular risk factors.

Aim: To assess the association between clinical characteristics of patients and telomere length in an unselected cohort of patients under the care of primary care physicians.

Methods: The LIPIDOGEN study was carried out in the primary care 2015. Patients recruited to LIPIDOGEN cohort (n=1788) were a random subset of patients of LIPIDOGRAM 2015 (n=13,724) study. Patients for LIPIDOGRAM2015/LIPIDOGEN study were recruited in all 16 administrative regions in Poland. Each patient was asked to fill the questionnaire on risk factors, chronic, treatment and lifestyle and also had saliva secured for DNA analyses. Factor Analysis for Mixed Data (FAMD) based cluster analysis was utilized to discern groups of patients with similar clinical profiles and correlate them with relative telomere length (rTL). RTL was measured using quantitative polymerase chain reaction.

Results: DNA quality was sufficient for further analyses in 1606 patients. After outlier exclusion, 1,342 patients (59.3% female, mean age 50.2 years) were analyzed. FAMD revealed two distinct clinical characteristic patterns, explaining 41.6% of the total variance in the clinical variables. The first pattern, correlated with male gender and a higher prevalence of MetS, hypertension, diabetes, obesity, greater waist circumference, elevated non-HDL-C and remnant-C levels, was linked to shorter rTL (r = -0.13, p < 0.001). The second pattern, characterized mainly by lipid parameters, showed no significant association with comorbidities or rTL (r = -0.04, p = 0.14).

Conclusions: Pattern of clinical characteristics marked by classical cardiovascular risk factors, is inversely related to telomere length, underlining the potential role of metabolic disturbances in cellular aging. The second lipid-centric pattern without significant comorbidities was not associated with telomere length.
  • Osadnik, Tadeusz  ( Medical University of Silesia in Katowice , Zabrze , Poland )
  • Gierlotka, Marek  ( University of Opole , Opole , Poland )
  • Golawski, Marcin  ( Medical University of Silesia in Katowice , Zabrze , Poland )
  • Osadnik, Kamila  ( Medical University of Silesia in Katowice , Zabrze , Poland )
  • Fronczek, Martyna  ( Medical University of Silesia in Katowice , Zabrze , Poland )
  • Gach, Agnieszka  ( Polish Mother’s Memorial Hospital Research Institute , Lodz , Poland )
  • Jozwiak, Jacek  ( University of Opole , Opole , Poland )
  • Banach, Maciej  ( Medical University of Lodz , Lodz , Poland )
  • Goc, Anna  ( University of Opole , Opole , Poland )
  • Boniewska-bernacka, Ewa  ( University of Opole , Opole , Poland )
  • Panczyszyn, Anna  ( University of Opole , Opole , Poland )
  • Lejawa, Mateusz  ( Medical University of Silesia in Katowice , Zabrze , Poland )
  • Strzelczyk, Joanna  ( Medical University of Silesia in Katowice , Zabrze , Poland )
  • Pawlas, Natalia  ( Medical University of Silesia in Katowice , Zabrze , Poland )
  • Krystek, Karol  ( Medical University of Silesia in Katowice , Zabrze , Poland )
  • Author Disclosures:
    Tadeusz Osadnik: DO NOT have relevant financial relationships | Marek Gierlotka: DO NOT have relevant financial relationships | Marcin Golawski: DO NOT have relevant financial relationships | Kamila Osadnik: No Answer | Martyna Fronczek: No Answer | Agnieszka Gach: DO NOT have relevant financial relationships | Jacek Jozwiak: No Answer | Maciej Banach: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen, Daichii-Sankyo, Mylan, and Sanofi:Past (completed) ; Speaker:Adamed, Amgen, Daiichi-Sankyo, Exceed-Pharma, Kogen, KRKA, MSD, NewAmsterdam, Novartis, Novo-Nordisk, Polpharma, Sanofi, Servier, Teva, Viatris and Zentiva:Active (exists now) ; Consultant:Adamed, Amgen, Daiichi-Sankyo, Esperion, MSD, NewAmsterdam, Novartis, Novo-Nordisk, Sanofi, Teva, Viatris:Active (exists now) | Anna Goc: No Answer | Ewa Boniewska-Bernacka: No Answer | Anna Panczyszyn: No Answer | Mateusz Lejawa: No Answer | Joanna Strzelczyk: No Answer | Natalia Pawlas: DO NOT have relevant financial relationships | Karol Krystek: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Clinical Cardiovascular Genetics

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
Assessing low-density lipoprotein cholesterol (LDL-C) equations in childhood for long-term risk of cardiovascular disease events: Superior performance of the Sampson equation

Meng Yaxing, Steinberger Julia, Urbina Elaine, Venn Alison, Viikari Jorma, Whitaker Kara, Woo Jessica, Raitakari Olli, Magnussen Costan, Wu Feitong, Juonala Markus, Jacobs David, Bazzano Lydia, Daniels Stephen, Dwyer Terence, Kahonen Mika, Sinaiko Alan

A Polygenic Score to Identify Risk of Incident Stroke and Benefit from Primary Prevention Statin Therapy

Mcclintick Daniel, Kamanu Frederick, Melloni Giorgio, Sabatine Marc, Ruff Christian, Ridker Paul, Chasman Daniel, Marston Nicholas

More abstracts from these authors:
Surveying Healthcare Professionals' Awareness and Management of Inflammation as a Residual Cardiovascular Risk Factor.

Banach Maciej, Postadzhiyan Arman, Moriarty Patrick, Vohnout Branislav, Jozwiak Jacek, Shapiro Michael, Wong Nathan, Surma Stanislaw, Alnouri Fahad, Mancini G B John, Vinereanu Dragos, Gouni-berthold Ioanna, Reiner Zeljko, Sabouret Pierre, Latkovskis Gustavs

The Restricted Fluid Intake Compared With Liberal Fluid Intake In Patients With Heart Failure – A Meta-Analysis

Bielecka-dabrowa Agata, Banach Maciej, Jaiswal Vikash

You have to be authorized to contact abstract author. Please, Login
Not Available